Drug & Supplement Interactions

Turmeric + Osimertinib Mesylate

Brand name of Osimertinib Mesylate

  • Tagrisso

Medically reviewed by

Also reviewed by the HelloPharmacist Editorial Team

Updated November 2026Details about this page

AI is used only to summarize verified clinical information, never the open internet. Our AI policy

The Bottom Line Moderate Interaction

Turmeric might increase or decrease levels of drugs metabolized by CYP3A4. Of the 2 interaction records for this pair, the most serious is rated moderate.

This also applies to Tagrisso, a brand name of osimertinib mesylate.

Read the Full Interaction Report Dr. Brian Staiger, PharmD, Explains What This Interaction Means for You Why it happens, what you might notice and what to do, in plain words.1-minute read
Moderate
Possible
2
D

Ask a Question About This Combination

Ask in your own words about taking Turmeric with Osimertinib Mesylate. The answer comes from this page’s own records.

Try:

AI answers from this page’s interaction records and our own drug and supplement information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist. How we use AI

Interaction Report

Turmeric and Osimertinib Mesylate Interaction

2 interaction records apply to these two. Each one is explained separately below.

Why Are There 2 Interaction Records?

We file Turmeric’s interactions under single medicines and under categories of medicines that share an effect. Osimertinib Mesylate is named in, or belongs to, 2 of them, so 2 records apply. They can describe the same effect, so they are not 2 separate risks. We’ve listed each one below; the most serious of them (Moderate) sets the overall rating.

Moderate Interaction 1 of 2

Turmeric With Cytochrome P450 3A4 (CYP3A4) Substrates

Why this applies to Osimertinib Mesylate

  1. The SupplementTurmeric
  2. Interacts With the CategoryCytochrome P450 3A4 (CYP3A4) Substrates
  3. Which IncludesOsimertinib Mesylate

We sort drugs into categories. Osimertinib Mesylate is in our Cytochrome P450 3A4 (CYP3A4) Substrates category, and Turmeric interacts with every drug in it, so this interaction applies to Osimertinib Mesylate.

Interaction Details Explained

Turmeric might increase or decrease levels of drugs metabolized by CYP3A4.
In vitro and animal research show that turmeric and its constituents curcumin and curcuminoids inhibit CYP3A4. Also, 8 case reports from the World Health Organization (WHO) adverse drug reaction database describe increased toxicity in patients taking turmeric and cancer medications that are CYP3A4 substrates, including everolimus, ruxolitinib, ibrutinib, and palbociclib, and bortezomib. In another case report, a transplant patient presented with acute nephrotoxicity and elevated tacrolimus levels after consuming turmeric powder at a dose of 15 or more spoonfuls daily for ten days prior. It was thought that turmeric increased levels of tacrolimus due to CYP3A4 inhibition.
Conversely, other in vitro research suggests that turmeric induces CYP3A4 activity, leading to reduced levels of CYP3A4 substrates. An animal model suggests that induction of CYP3A4 occurs after daily curcumin use for 1 week. However, the induction of CYP3A4 by turmeric has not been reported in humans.
Severity
ModerateUse caution: it may call for monitoring, timing changes or a dose change.
Likelihood
PossibleSeen in lab or animal research, or in people only in case reports or mixed results.
Evidence
Grade DBased on lab or animal research, not studies in people.

What every rating means

Dr. Brian Staiger, PharmD, BCPS
Explaining the Turmeric + Cytochrome P450 3A4 (CYP3A4) Substrates Interaction in Plain Words By Dr. Brian Staiger, PharmD, clinical pharmacist

Here's the gist: your lung cancer medicine osimertinib (Tagrisso) is processed by a liver enzyme called CYP3A4, and turmeric may nudge that enzyme in either direction. If turmeric slows it down, osimertinib could build up and you might see more side effects like diarrhea, mouth sores, rash, dry skin, or fatigue. If turmeric instead speeds the enzyme up, levels could dip and the medicine may not work as well against the cancer, which matters a lot here.

Honestly, the evidence is thin, mostly lab and animal studies plus a few scattered case reports with other cancer drugs. The small amount in your cooking is very unlikely to be a problem. Concentrated curcumin capsules are the real question. Since this is cancer treatment, please run any turmeric supplement past your oncologist or pharmacist first.

Still have a question about this interaction?

Contact Dr. Brian directly

References 7 sources behind this record

  1. Appiah-Opong, R., Commandeur, J. N., Vugt-Lussenburg, B., and Vermeulen, N. P. Inhibition of human recombinant cytochrome P450s by curcumin and curcumin decomposition products. Toxicology 6-3-2007;235(1-2):83-91. PubMed
  2. Hou, X. L., Takahashi, K., Kinoshita, N., Qiu, F., Tanaka, K., Komatsu, K., Takahashi, K., and Azuma, J. Possible inhibitory mechanism of Curcuma drugs on CYP3A4 in 1alpha,25 dihydroxyvitamin D3 treated Caco-2 cells. Int.J Pharm 6-7-2007;337(1-2):169-177.
  3. Valentine, S. P., Le Nedelec, M. J., Menzies, A. R., Scandlyn, M. J., Goodin, M. G., and Rosengren, R. J. Curcumin modulates drug metabolizing enzymes in the female Swiss Webster mouse. Life Sci. 4-11-2006;78(20):2391-2398. PubMed
  4. Nayeri A, Wu S, Adams E, et al. Acute Calcineurin Inhibitor Nephrotoxicity Secondary to Turmeric Intake: A Case Report. Transplant Proc. 2017;49(1):198-200. PubMed
  5. Haron MH, Dale O, Martin K, et al. Evaluation of the Herb-Drug Interaction Potential of Commonly Used Botanicals on the US Market with Regard to PXR- and AhR-Mediated Influences on CYP3A4 and CYP1A2. J Diet Suppl 2022. PubMed
  6. Pochet S, Lechon AS, Lescrainier C, et al. Herb-anticancer drug interactions in real life based on VigiBase, the WHO global database. Sci Rep 2022;12(1):14178. PubMed
  7. Dibaei M, Hosseini A, Lavasani H, Kiani-Dehkordi B, Rouini M. Assessment of metabolic interaction between curcumin and tramadol using the isolated perfused rat liver. Heliyon 2024;10(15):e35070. PubMed
Minor Interaction 2 of 2

Turmeric With P-glycoprotein Substrates

Osimertinib Mesylate is also in our P-glycoprotein Substrates category.

Interaction Details Explained

Theoretically, turmeric might increase the absorption of P-glycoprotein substrates.
In vitro and animal research shows that curcuminoids and other constituents found in turmeric can inhibit P-glycoprotein expression and activity.
Severity
MinorLimited concern, but worth mentioning to your pharmacist.
Likelihood
PossibleSeen in lab or animal research, or in people only in case reports or mixed results.
Evidence
Grade DBased on lab or animal research, not studies in people.

What every rating means

Dr. Brian Staiger, PharmD, BCPS
Explaining the Turmeric + P-glycoprotein Substrates Interaction in Plain Words By Dr. Brian Staiger, PharmD, clinical pharmacist

Here's the basic idea with turmeric and your osimertinib (Tagrisso). Osimertinib is carried around by a little cellular pump called P-glycoprotein. Lab and animal studies hint that the curcumin in turmeric might slow that pump down. If that happened in people, a bit more osimertinib could get absorbed, which in theory might mean more of the usual side effects, things like diarrhea, mouth sores, rash, or dry skin.

The important part: this is only theoretical, based on test-tube and animal work, and it's rated a minor interaction. The amount of turmeric you'd sprinkle on food is very unlikely to matter. Concentrated curcumin supplements are a different story, so since osimertinib is a serious cancer medicine, please run any turmeric supplement past your oncologist or pharmacist first.

Still have a question about this interaction?

Contact Dr. Brian directly

References 12 sources behind this record

  1. Junyaprasert, V. B., Soonthornchareonnon, N., Thongpraditchote, S., Murakami, T., and Takano, M. Inhibitory effect of Thai plant extracts on P-glycoprotein mediated efflux. Phytother.Res 2006;20(1):79-81. PubMed
  2. Ampasavate, C., Sotanaphun, U., Phattanawasin, P., and Piyapolrungroj, N. Effects of Curcuma spp. on P-glycoprotein function. Phytomedicine. 2010;17(7):506-512. PubMed
  3. Hou, X. L., Takahashi, K., Tanaka, K., Tougou, K., Qiu, F., Komatsu, K., Takahashi, K., and Azuma, J. Curcuma drugs and curcumin regulate the expression and function of P-gp in Caco-2 cells in completely opposite ways. Int.J Pharm 6-24-2008;358(1-2):224-2 PubMed
  4. Choi, B. H., Kim, C. G., Lim, Y., Shin, S. Y., and Lee, Y. H. Curcumin down-regulates the multidrug-resistance mdr1b gene by inhibiting the PI3K/Akt/NF kappa B pathway. Cancer Lett. 1-18-2008;259(1):111-118.
  5. Zhang, W., Tan, T. M., and Lim, L. Y. Impact of curcumin-induced changes in P-glycoprotein and CYP3A expression on the pharmacokinetics of peroral celiprolol and midazolam in rats. Drug Metab Dispos. 2007;35(1):110-115. PubMed
  6. Limtrakul, P., Chearwae, W., Shukla, S., Phisalphong, C., and Ambudkar, S. V. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocu
  7. Holland, M. L., Panetta, J. A., Hoskins, J. M., Bebawy, M., Roufogalis, B. D., Allen, J. D., and Arnold, J. C. The effects of cannabinoids on P-glycoprotein transport and expression in multidrug resistant cells. Biochem.Pharmacol 4-14-2006;71(8):1146-1154 PubMed
  8. Tang, X. Q., Bi, H., Feng, J. Q., and Cao, J. G. Effect of curcumin on multidrug resistance in resistant human gastric carcinoma cell line SGC7901/VCR. Acta Pharmacol Sin. 2005;26(8):1009-1016. PubMed
  9. Nabekura, T., Kamiyama, S., and Kitagawa, S. Effects of dietary chemopreventive phytochemicals on P-glycoprotein function. Biochem.Biophys.Res Commun. 2-18-2005;327(3):866-870. PubMed
  10. Romiti, N., Tongiani, R., Cervelli, F., and Chieli, E. Effects of curcumin on P-glycoprotein in primary cultures of rat hepatocytes. Life Sci. 1998;62(25):2349-2358. PubMed
  11. Yue, G. G., Cheng, S. W., Yu, H., Xu, Z. S., Lee, J. K., Hon, P. M., Lee, M. Y., Kennelly, E. J., Deng, G., Yeung, S. K., Cassileth, B. R., Fung, K. P., Leung, P. C., and Lau, C. B. The role of turmerones on curcumin transportation and P-glycoprotein acti
  12. Pochet S, Lechon AS, Lescrainier C, et al. Herb-anticancer drug interactions in real life based on VigiBase, the WHO global database. Sci Rep 2022;12(1):14178. PubMed
Know someone taking this combination? Share

Beyond the Record

What Else We Found About Turmeric and Osimertinib Mesylate

Pharmacist Q&AYou ask. We answer.

Questions Our Pharmacists Have Answered About Turmeric and Osimertinib Mesylate

Real questions from readers, each answered by a licensed pharmacist at HelloPharmacist, written by a person and not generated from a database. An answer is written for the reader who asked and their situation, so read it for what to ask your own pharmacist rather than as a plan to follow.

Each one covers Turmeric or Osimertinib Mesylate, not necessarily both.

  1. The pharmacist says

    Krill oil can be safely taken with lacosamide because omega-3 fats don't interfere with how your body clears the medication. Turmeric has a possible mild interaction with lacosamide through effects on liver enzymes, so mention it to your neurologist or pharmacist and keep your dose consistent. Both krill oil and turmeric have a mild blood-thinning effect that matters mainly if you take blood thinners, have a bleeding disorder, or have surgery planned. Taking krill oil with food can help reduce stomach upset from lacosamide and improve turmeric absorption at the same time.

    Answered by Dr. Brian Staiger, PharmD · October 2026
  2. The pharmacist says

    Red yeast rice can interact with Tagrisso because Tagrisso blocks an enzyme that breaks down red yeast rice, potentially causing it to build up in your blood. This interaction may increase the risk of muscle pain and weakness similar to side effects seen with statin medications. It's important to tell your doctor about all supplements you're taking, including red yeast rice, and report any muscle symptoms that develop.

    Answered by Dr. Brian Staiger, PharmD · February 2023
  3. The pharmacist says

    Turmeric supplements may raise amlodipine levels in your body and strengthen its blood pressure lowering effect, which could cause dizziness, lightheadedness, flushing, or increased swelling.

    Answered by Dr. Brian Staiger, PharmD · July 2026
  4. The pharmacist says

    The Premier Fermented Mushroom Blend contains only minimal amounts of green tea caffeine, which is unlikely to cause problems when taking Tagrisso. None of the other ingredients in this supplement are known to have clinically significant interactions with Tagrisso. Always inform your doctor about all supplements you're taking so they can monitor you appropriately, since there is often limited data on natural product interactions.

    Answered by Dr. Brian Staiger, PharmD · January 2023
Published Research

Studies That Mention Both Turmeric and Osimertinib Mesylate

lists 1 record naming both. These are the most relevant that discuss the two together. Mentioning both is not a finding about taking them together, so treat them as a starting point.

  1. Food constituent- and herb-drug interactions in oncology: Influence of quantitative modelling on Drug labelling. British Journal of Clinical Pharmacology · 2021 · In people · PMID 33733472

Reports to the FDA

36 reports to the FDA list both Turmeric and Osimertinib Mesylate.

What this means: someone took both, then had a health problem. It does not show either one caused it. In 5 of the 5 newest reports, Turmeric or Osimertinib Mesylate was the suspect or was flagged as interacting. The reports below say which.

  • 36Reports that list both
  • 31Marked serious by the reporter
  • 10From doctors, pharmacists and other health professionals
  • 23From patients and other consumers
The 5 Newest Reports
Who sent them, what happened and which medicine was suspected
ReceivedReported byWhat happenedMedicine suspectedTurmericOsimertinib Mesylate
June 2026Report 26832854 A consumer DeathSerious: death Osimertinib13 products listed Also taking Suspected
March 2026Report 26504517 A consumer Intestinal perforation, DiverticulitisSerious: hospital stay Osimertinib13 products listed Also taking Suspected
October 2025Report 25936607 A consumer Lower limb fracture, Tiredness (asthenia), PainSerious: medically important Osimertinib4 products listed Also taking Suspected
August 2024Report 24208665 A consumer Illness, Product dose omission issueSerious: hospital stay Tagrisso5 products listed Also taking Suspected
August 2024Report 24186354 A consumer Bowel blockage (small intestinal obstruction)Serious: hospital stay Tagrisso12 products listed Also taking Suspected
Problems Named Most Often

Across all 36 reports, whatever was suspected. Not what this pair causes.

  • Death9
  • Reduced appetite (decreased appetite)5
  • Change in taste (dysgeusia)5
  • Diarrhea4
  • Diverticulitis4
  • Migraine4
How we searched

PubMed: searched October 2026, and again every few months. PubMed lists research but does not grade it; the rating above comes from our interaction records.

FDA reports: from the FDA Adverse Event Reporting System (FAERS) through openFDA, read October 2026. Matched by name, so a report may name a product that contains Turmeric. The counts are reports, not people, and no one checks them for cause. What FAERS is.

Your Whole Routine

Your Other Medicines and Supplements

Keep It in Perspective

Turmeric Also Interacts With Other Medications

Besides Osimertinib Mesylate, Turmeric has 1,057 moderate, 76 minor known drug interactions in our database. If you take anything else, check it against the full list below.

Taking Anything Else?

Check Another of Your Medications Against Turmeric

Covers the 2,830 medications we’ve checked against Turmeric. Pick one to open its full report.

Everything Else You Take

See Every Supplement That Interacts With Osimertinib Mesylate

Take other supplements too? 169 supplements have a documented interaction with Osimertinib Mesylate, each explained on its page.

By severity: 8 major, 120 moderate and 41 minor.

The Most Serious There Right Now:

Open the Osimertinib Mesylate interaction pageEvery supplement checked against Osimertinib Mesylate, ranked by severity
One More Smart Check

Taking Turmeric as Part of a Dietary Supplement Product? Check It for Interactions

A product can hold more than Turmeric. We have broken down 1,368 supplement products that contain it, ingredient by ingredient. Find yours and we’ll check every ingredient against Osimertinib Mesylate:

Get to Know Each One

About Turmeric and Osimertinib Mesylate

Supplement

About Turmeric

Turmeric

Turmeric is a popular spice whose main active compounds, curcuminoids, are studied mostly for inflammation and joint pain. Some research is promising, but quality is mixed and curcumin is poorly absorbed on its own. For most people, dietary amounts are safe, but talk to your pharmacist or doctor before taking concentrated supplements, especially if you are pregnant, nursing, or have a medical condition.

Full Turmeric guide: uses, dosage, safety and every interaction
Medication

About Osimertinib

Brand name: Tagrisso

Osimertinib treats adults with non-small cell lung cancer (NSCLC) whose tumors have certain changes in the EGFR gene. An FDA-approved test is used to confirm the mutation.

Osimertinib: uses, dosage and side effects Osimertinib: interactions with other drugs Taking more than these two? Check Turmeric and Osimertinib with everything else you take Osimertinib NDC codes and packages

More to Explore

More Pairs and Interactions to Check

Similar Pairs

More Pairs Like Turmeric and Osimertinib Mesylate

Other drugs in the category this interaction applies to, and other supplements people check with Osimertinib Mesylate.

Moderate

Also in Our Cytochrome P450 3A4 (CYP3A4) Substrates Category

Turmeric interacts with every drug in this category, so each of these has the same interaction. The category is about a shared effect, not about being the same kind of medicine.

Show all 16 drugs in this categoryShow fewer

384 more in this category are on the Turmeric interactions list.

Minor

Also in Our P-glycoprotein Substrates Category

Turmeric interacts with every drug in this category, so each of these has the same interaction. The category is about a shared effect, not about being the same kind of medicine.

Show all 16 drugs in this categoryShow fewer

185 more in this category are on the Turmeric interactions list.

Other Supplements With Osimertinib Mesylate

The most serious documented interactions with Osimertinib Mesylate first, then supplements with none on record, the most looked-up leading.

Show all 25 supplementsShow fewer
Keep Checking

Other Drugs & Turmeric

Browse every other medication we’ve checked against Turmeric — both the ones with a known interaction and the ones without. Select any drug for the full detail.

0Major
1,057Moderate
76Minor
1,696No known interaction
Moderate

Moderate: 1,057 interactions

Showing 60 of 1,057 moderate interactions — see all 1,057 on the Turmeric page.

Minor

Minor: 76 interactions

Showing 60 of 76 minor interactions — see all 76 on the Turmeric page.

No Interaction 1,696 drugs checked — show the list
How Much People Look This Up

Where Turmeric and Osimertinib Mesylate Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement Turmeric
Top 5%

#19 of 1,458 supplements looked up here in the last 7 days

29 days ago today
Medication Osimertinib Mesylate
Top half

#1,407 of 2,830 medications looked up here in the last 7 days

29 days ago today

A rank of lookups on this site, not of how often either one is used. It counts every visit, automated ones included, and identifies no one.

Questions and Sources

Common Questions and Where This Comes From

Pharmacist Counseling Corner

Taking Turmeric and Osimertinib Mesylate Together: Common Questions

Can you take Turmeric with Osimertinib Mesylate?
There is a moderate interaction, so it may be acceptable with monitoring or timing changes. Read the full details on this page and confirm with your pharmacist before combining them.
Can you take Turmeric with Tagrisso?
Tagrisso is a brand name of osimertinib mesylate, so the answer is the same as for osimertinib mesylate. There is a moderate interaction, so it may be acceptable with monitoring or timing changes. Everything on this page applies to Tagrisso too.
Why are there 2 interaction records for Turmeric and Osimertinib Mesylate?
We file interactions under single medicines and under categories of medicines that share an effect. Osimertinib Mesylate is named in, or belongs to, 2 of the categories we list for Turmeric, so 2 records apply. They can describe the same effect, so they are not 2 separate risks. We list every one so nothing is missed, and the most serious one sets the overall rating.
How serious is the Turmeric and Osimertinib Mesylate interaction?
We rate it Moderate. This combination may require monitoring, a dose adjustment, or separating the times you take each one. Consult your pharmacist before using them together.
Has Turmeric been studied with Osimertinib Mesylate?
We searched PubMed, the National Library of Medicine's index of medical research, in October 2026. It lists 1 record that name both Turmeric and Osimertinib Mesylate; the most relevant that discuss the two together are listed on this page with links to PubMed. A study that discusses both is not a finding about taking them together.

Written and reviewed by the HelloPharmacist Editorial Team. Our editorial policy

Sources

Sources & How We Checked

Interaction details are evidence-graded and sourced from the Natural Medicines database. The medication overview comes from MedlinePlus.

Content is reviewed by the HelloPharmacist Editorial Team, the pharmacists on our staff and those we contract. See our data sources and editorial standards for how this information is built and checked.

Parts of this content are provided by the Therapeutic Research Center, LLC.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Keep Exploring
Rating Key

What Our Interaction Ratings Mean

Every interaction on this page is rated three ways: how serious it is, how likely it is to happen, and how strong the research behind it is.

See what each rating means

Severity: How Serious Is It?

How clinically significant the interaction is: how much it could affect your health or your treatment.

  • MajorClinically significant. Best to avoid the combination, or use only under close professional supervision.
  • ModerateBe cautious. The combination may call for monitoring, timing changes, or a dose adjustment.
  • MinorLimited clinical concern, but still worth being aware of and mentioning to your pharmacist.
  • No Known InteractionNo documented interaction in our sources.

Likelihood: How Likely Is It to Happen?

How strong the proof is that the interaction really happens in people. More filled steps, stronger proof.

  • LikelyShown in well-controlled studies in people.
  • ProbableShown in small studies in people, or in animal studies backed by case reports.
  • PossibleSeen in lab or animal research, or in people only in case reports or mixed results.
  • UnlikelySeen in lab or animal research, but shown not to happen in people.

Evidence: How Strong Is the Research?

The quality of the studies behind the rating, graded from A, the strongest, to D.

  • Grade AStrong: well-run randomized trials in people, or a review that pooled several of them.
  • Grade BFair: smaller or less rigorous trials in people, or studies that followed or compared groups of people.
  • Grade CLimited: the agreement or opinion of experts, not studies.
  • Grade DWeak: reports of single cases, lab or animal research, or what is expected from how the two work.

Still Have a Question About Turmeric and Osimertinib Mesylate?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.